 Congress 2018.png)
May
Continuing Medical Education (CME) Credits
An application will be made to the UEMS-EACCME® for CME accreditation of this meeting. Further information and instructions on how to receive your CME credits will be included in the Final Programme and will be available online closer to the event.
Welcome to Munich 2018 - Where Invention and Innovation Accelerates!
The European Academy of Allergy and Clinical Immunology will host in Munich in 2018 the world's largest and most influential allergy, asthma and clinical immunology meeting.
Boasting a proud history of scientific innovation and medical discoveries and with a spirit of collaboration, openness and information-sharing Munich is a fitting choice for the EAACI Annual Congress. Many of the world's most famous innovative thinkers that redefined the course of modern human civilization have lived and worked in the capital of Bavaria. Munich is firmly branded as a center of expertise in R&D and innovation. The city’s innovation-friendly climate encourages proactive development work and close cooperation among clinics, universities and research organizations. All told, the Munich area is one of the most research-intensive regions of Germany. The Fraunhofer Society for the Promotion of Applied Research, the Max Planck Society for the Promotion of Science, Munich’s Helmholtz Center for Environmental Health, the Technical University, the Ludwig-Maximilian’s University, the Center for Integrated Protein Science and the Munich Center for Advanced Protonics are just a few examples of Munich at its research-rich best.
Progress happens when great minds work together to solve the toughest challenges. One of the EAACI’s greatest achievements is its ability to create partnerships and communities to accelerate the rate of invention and innovation. Currently, there are no treatment modalities that can cure allergy. Therefore extensive efforts in innovative prevention, monitoring and immune modulation interventions together with integrative approaches are needed to circumvent the unmet needs in allergy and asthma. Such innovative solutions ultimately lead to better patient outcomes, fewer hospital visits and reduced healthcare costs. Through research, education, community outreach, and talent development, the allergy community needs to promote a transformational impact on how we understand and manage allergic diseases and asthma.
The Scientific Programme will present the best in science and educational sessions from distinguished researchers from across the globe. Covering key topics in allergic diseases and asthma the EAACI Annual Congress provides a multidisciplinary forum for allergists, pulmonologists, ENTs, dermatologists, internists, pediatricians, gastroenterologists, clinical immunologists and primary care physicians.
I look forward to welcoming participants and friends from around the world to the EAACI Annual Congress where we will continue our mission to drive standards in allergy and clinical immunology. These meetings would not be possible without your continuous endeavor for high quality learning opportunities and scientific interactions. Join EAACI to celebrate innovation as the game-changing approach to the complex health, social, economic, environmental and technical challenges posed by allergy and asthma.
Dr. Ioana Agache
EAACI President 2017-2019
EUR
We don’t accept Online Abstracts
K.I.T. Group has been appointed as the official and exclusive housing agent for the EAACI Congress 2018. Your hotel reservations will be part of the congress block and the K.I.T. Group will be available to provide support before the congress as well as onsite. EAACI strongly recommends delegates to book via the K.I.T. Group, as we are aware of fraudulent groups acting as housing agents that claim to be associated with the congress. Regretfully, we cannot offer any support with any bookings made via these fraudulent companies.
Hotels in Munich
A number of hotels in different categories have been pre-booked at preferential rates for the congress. Rates include breakfast and local VAT. The hotels are located both near the congress venue and in the city centre with convenient and fast routes to the congress venue. Room availability is guaranteed by the Congress Secretariat until 12 March 2018.
Book your hotel accommodation ahead of time and benefit from the best rates and selections.
Group Bookings
Please note that group reservations, 10 rooms or more, will be handled with separate contracts and separate regulations. Please contact eaaci2018hotels@eaaci.org for further information.
Booking and Payment of Individual Hotel Reservation
Delegates have the possibility to decide on the type of payment (bank transfer or credit card payment) until 12 March 2018. If payment by bank transfer is chosen, a “payment order” will be sent out by e-mail to the requesting delegate, which should be settled within a week’s time.
If payment by credit card is chosen, K.I.T. Group will charge a deposit of 35 EUR per room at the end of the online booking process.
Full payment of the entire accommodation must be made by 12 March 2018. On the same day, K.I.T. Group will also charge the remaining balance due for the entire hotel booking to all credit cards.
After 12 March 2018 only credit card payments will be accepted and the full amount due for the entire hotel booking will be debited to your credit card at the end of the online booking process.
Cancellation and Change of Individual Hotel Reservation
Cancellations and changes must be made in writing with the EAACI Congress 2018 Accommodation Team at any time. Please note that hotels will not accept any changes or cancellations directly. K.I.T. Group will retain the deposit of 35 EUR for cancellations received before 12 March 2018. For cancellations received after 12 March 2018, your credit card will be charged with an amount equalling the full value of the cancelled nights. This does also apply for a reduction in the length of stay if notified after 12 March 2018. No shows will be released automatically by the hotel at 9 am the following day, and the accommodation fee will not be refundable.
More Information
K.I.T. Group on behalf of EAACI
Telephone: +49 30 246 03 430
eaaci2018hotels@eaaci.org
Call for Abstracts and Abstract Submission Guidelines
The EAACI Scientific Programme Committee and the Local Organising Committee welcome the submission of original contributions for oral and poster presentation at the Congress.
DEADLINE: 15 JANUARY 2018 at 24:00 CET
Instructions to authors
Carefully read the guidelines below before submitting your abstract. Acknowledgement of the receipt of your submission will be sent to the corresponding author’s e-mail address immediately upon submission. If you do not receive the confirmation e-mail, please do not submit the abstract again. Instead please contact the Abstract team at eaaci2018abstract@eaaci.org for advice. Invited speakers are not required to submit abstracts to the lectures they are invited to.
Submission guidelines
• Abstracts can only be submitted electronically through the congress website.
• You are allowed to be the presenting author of more than one abstract.
• You are allowed to be a co-author of more than one abstract.
• Submissions of similar abstracts from the same group are discouraged.
• Abstracts that have been or will be presented at a different scientific meeting during a 12 months period prior to EAACI 2018 can be submitted.
• Please note, a confirmation of consent must be provided in cases where patients, both living or deceased, are visibly identifiable.Should consent not be given, any pictures must be made anonymous by placing sufficient coverage over any identifiable elements; eyes, facial features, characterising marks etc.
Personal page
When entering the abstract submission system for the first time, you will be asked to create a profile. Through your account you will be able to access your personal page to submit one or several abstracts. You can edit your abstracts until the submission deadline, 15 January 2018.
Abstract language and length
Abstracts and presentations must be written in English. The maximum length allowed for an abstract is 2500 characters (approximately 350 words) including blank spaces. The abstract title, the author(s) or names of institutions are not included in the count of 2500 characters.
Abstract structure and content
In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study and/or the underlying hypotheses, the method used, the results observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You may subtitle the paragraphs in the following order: Background, Method, Results, and Conclusion.
Tables/Pictures
50 characters per row will be deducted from the word count.
No pictures are allowed.
The abstract title and body text should only include pharmacopoeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required the first time a drug is mentioned in the text. References, credits or the authors’ academic degrees or grant support are not to be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text. Company names are not allowed in the title but can be named in the authors’ affiliation.
Consent for publication of individual patient data - applies to abstracts with identifiable patient information
For the publication of an abstract that contains identifiable information about patients, it is necessary that patients have given consent for the research to be published. For all abstracts that include identifiable patient details (e.g. gender, age, illness, location) or images, written informed consent for the publication of these must be obtained from the patient (or their parent or legal guardian).
It is the author’s responsibility to obtain written informed consent for publication of clinical details and/or clinical images from the patient/parent/guardian/relative of the patient. A respective statement needs to be included in the abstract text.
Duplication of publications
Abstracts containing data that has been presented or will be presented at a different scientific meeting during a 12 months period prior to EAACI 2018 can be submitted.
Declaration of conflict of interest
EAACI is committed to ensuring the integrity of its scientific, educational, and research programmes. Abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.
Contact No.: +41 44 205 55 33
Email: info@eaaci.org, eaaci2018@eaaci.org
| Company Sponsored Symposium (CSS 1) ALK 10:30 – 12:00 |  |
| Company Sponsored Symposium (CSS 2) Novartis Pharma AG 13:30 – 15:00 |  |
| Company Sponsored Symposium (CSS 3) AstraZeneca 15:30 – 17:00 |  |
| Company Sponsored Symposium (CSS 4) Mylan 10:45 – 12:15 |  |
| Company Sponsored Symposium (CSS 5) HAL Allergy 13:45 – 15:15 |  |
| Company Sponsored Symposium (CSS 6) Allergopharma GmbH & Co. KG 15:45 – 17:15 |  |
| Company Sponsored Symposium (CSS 7) Thermo Fisher Scientific 10:30 - 12:00 |  |
| Company Sponsored Symposium (CSS 8)STALLERGENES GREER 13:30 – 15:00 |  |
Contact No.: +41 44 205 55 33
Email: info@eaaci.org, eaaci2018@eaaci.org